Search research articles
Contact Us
Filters
Showing results (1-10 of 33) with videos related to
Page
of 4
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 29, 2024
[Clinical and genetic features of MDS associated with VEXAS syndrome]
Hiroyoshi Kunimoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 2, 2024
[Epigenetic dysregulation and emerging treatment strategies in myelodysplastic syndromes]
Hiroyoshi Kunimoto
Leukemia Research
|
October 3, 2020
Clonal hematopoiesis: Molecular basis and clinical relevance
Hiroyoshi Kunimoto, Hideaki Nakajima
Cancer Science
|
October 13, 2020
TET2: A cornerstone in normal and malignant hematopoiesis
Hiroyoshi Kunimoto, Hideaki Nakajima
International Journal of Hematology
|
May 31, 2017
Epigenetic dysregulation of hematopoietic stem cells and preleukemic state
Hiroyoshi Kunimoto, Hideaki Nakajima
International Journal of Hematology
|
May 31, 2024
VEXAS syndrome
Hideaki Nakajima, Hiroyoshi Kunimoto
Cancer Science
|
July 22, 2014
TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
Hideaki Nakajima, Hiroyoshi Kunimoto
Stem Cells (Dayton, Ohio)
|
October 9, 2023
O-Linked N-Acetylglucosamine Transferase Ensures Survival of Mouse Fetal Liver Hematopoietic Progenitors Partly by Regulating Bcl-xL and Oxidative Phosphorylation
Shunsuke Soma, Koichi Murakami, Yumi Fukuchi, et al.
Ejhaem
|
December 18, 2024
Successful treatment of low-risk myelodysplastic syndrome-related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
Hiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, et al.
Scientific Reports
|
February 23, 2012
Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells
Hiroyoshi Kunimoto, Yumi Fukuchi, Masatoshi Sakurai, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 33) with videos related to
Sort By:
Page
of 4
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 29, 2024
[Clinical and genetic features of MDS associated with VEXAS syndrome]
Hiroyoshi Kunimoto
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
June 2, 2024
[Epigenetic dysregulation and emerging treatment strategies in myelodysplastic syndromes]
Hiroyoshi Kunimoto
Leukemia Research
|
October 3, 2020
Clonal hematopoiesis: Molecular basis and clinical relevance
Hiroyoshi Kunimoto, Hideaki Nakajima
Cancer Science
|
October 13, 2020
TET2: A cornerstone in normal and malignant hematopoiesis
Hiroyoshi Kunimoto, Hideaki Nakajima
International Journal of Hematology
|
May 31, 2017
Epigenetic dysregulation of hematopoietic stem cells and preleukemic state
Hiroyoshi Kunimoto, Hideaki Nakajima
International Journal of Hematology
|
May 31, 2024
VEXAS syndrome
Hideaki Nakajima, Hiroyoshi Kunimoto
Cancer Science
|
July 22, 2014
TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
Hideaki Nakajima, Hiroyoshi Kunimoto
Stem Cells (Dayton, Ohio)
|
October 9, 2023
O-Linked N-Acetylglucosamine Transferase Ensures Survival of Mouse Fetal Liver Hematopoietic Progenitors Partly by Regulating Bcl-xL and Oxidative Phosphorylation
Shunsuke Soma, Koichi Murakami, Yumi Fukuchi, et al.
Ejhaem
|
December 18, 2024
Successful treatment of low-risk myelodysplastic syndrome-related anemia in patients with chronic kidney disease with daprodustat: A report of two cases
Hiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, et al.
Scientific Reports
|
February 23, 2012
Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells
Hiroyoshi Kunimoto, Yumi Fukuchi, Masatoshi Sakurai, et al.
Page
of 4